ECHO Study Fact Sheet The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study is an open-label randomised clinical trial comparing three highly effective, reversible methods of contraception — a progestogen-only injectable called depot-medroxyprogesterone...
Planning for Outcomes (P4O) Model FAQs Frequently asked questions about the P4O model for estimating the impact of removing injectables from the contraceptive method mix. Published: 2018 Source: FHI360 Back to...
Contraception and HIV Prevention: A Clear Picture of Women’s Needs An infographic illustrating the need for integrated family planning and HIV services. Published: 2018 Source: AVAC Back to...
A Brief Guide to the Planning for Outcomes (P4O) Model A guide to using the P4O model for estimating the impact of removing injectables from the contraceptive method mix. Published: 2018 Source: FHI360 Back to...
Presentation: Update on the ECHO Trial Presentation to the International AIDS Conference, 2018 in Amsterdam by Dr. Helen Rees on behalf of the ECHO consortium. Published: 2018 Source: ECHO Back to...
Recent Comments